
No. of Pages: 150 | Report Code: TIPRE00018855 | Category: Life Sciences
No. of Pages: 150 | Report Code: TIPRE00018855 | Category: Life Sciences
1.1 Report Guidance
1.2 Market Segmentation
2.1 Key Insights
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4.1 Market Drivers
4.1.1 Increasing Demand for Tumor Modeling and Biobanking
4.1.2 Surging Adoption of Personalized Drugs
4.2 Market Restraints
4.2.1 Dearth of Skilled Professionals
4.3 Market Opportunities
4.3.1 Focus on Drug Discovery Activities
4.4 Future Trends
4.4.1 Combination of Organoids and Organ-on-a-Chip
4.5 Impact of Drivers and Restraints:
5.1 Middle East & Africa Organoids Market Revenue (US$ Million), 2021–2031
5.2 Middle East & Africa Organoids Market Forecast Analysis
6.1 Intestine
6.1.1 Overview
6.1.2 Intestine: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
6.2 Liver
6.2.1 Overview
6.2.2 Liver: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
6.3 Stomach
6.3.1 Overview
6.3.2 Stomach: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
6.4 Pancreas
6.4.1 Overview
6.4.2 Pancreas: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
6.5 Lung
6.5.1 Overview
6.5.2 Lung: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
6.6 Brain
6.6.1 Overview
6.6.2 Brain: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
6.7 Kidney
6.7.1 Overview
6.7.2 Kidney: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
6.8 Others
6.8.1 Overview
6.8.2 Others: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
7.1 Developmental Biology Disease
7.1.1 Overview
7.1.2 Developmental Biology Disease: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
7.2 Pathology of Infectious Disease
7.2.1 Overview
7.2.2 Pathology of Infectious Disease: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
7.3 Regenerative Medicine
7.3.1 Overview
7.3.2 Regenerative Medicine: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
7.4 Drug Toxicity and Efficacy Testing
7.4.1 Overview
7.4.2 Drug Toxicity and Efficacy Testing: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
7.5 Drug Discovery and Personalized Medicine
7.5.1 Overview
7.5.2 Drug Discovery and Personalized Medicine: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
8.1 Pluripotent Stem Cells
8.1.1 Overview
8.1.2 Pluripotent Stem Cells: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
8.2 Organ-Specific Adult Stem Cell
8.2.1 Overview
8.2.2 Organ-Specific Adult Stem Cell: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
9.1 Instruments
9.1.1 Overview
9.1.2 Instruments: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
9.2 Consumables
9.2.1 Overview
9.2.2 Consumables: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
9.3 Services
9.3.1 Overview
9.3.2 Services: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.1 Micropatterned Plates
10.1.1 Overview
10.1.2 Micropatterned Plates: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.2 Ultralow Attachment Plates
10.2.1 Overview
10.2.2 Ultralow Attachment Plates: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.3 Hanging Drop
10.3.1 Overview
10.3.2 Hanging Drop: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.4 Microdroplet or Emulsion
10.4.1 Overview
10.4.2 Microdroplet or Emulsion: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.5 Others
10.5.1 Overview
10.5.2 Others: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.1 Middle East & Africa
11.1.1 Middle East & Africa Organoids Market – Revenue and Forecast Analysis – by Country
11.1.1.1 Middle East & Africa Organoids Market – Revenue and Forecast Analysis – by Country
11.1.1.2 Saudi Arabia: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.1.1.2.1 Saudi Arabia: Middle East & Africa Organoids Market Share – by Type
11.1.1.2.2 Saudi Arabia: Middle East & Africa Organoids Market Share – by Application
11.1.1.2.3 Saudi Arabia: Middle East & Africa Organoids Market Share – by Source
11.1.1.2.4 Saudi Arabia: Middle East & Africa Organoids Market Share – by Offering
11.1.1.2.5 Saudi Arabia: Middle East & Africa Organoids Market Share – by Instruments
11.1.1.2.6 Saudi Arabia: Middle East & Africa Organoids Market Share – by Consumables
11.1.1.2.7 Saudi Arabia: Middle East & Africa Organoids Market Share – by Method
11.1.1.3 South Africa: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.1.1.3.1 South Africa: Middle East & Africa Organoids Market Share – by Type
11.1.1.3.2 South Africa: Middle East & Africa Organoids Market Share – by Application
11.1.1.3.3 South Africa: Middle East & Africa Organoids Market Share – by Source
11.1.1.3.4 South Africa: Middle East & Africa Organoids Market Share – by Offering
11.1.1.3.5 South Africa: Middle East & Africa Organoids Market Share – by Instruments
11.1.1.3.6 South Africa: Middle East & Africa Organoids Market Share – by Consumables
11.1.1.3.7 South Africa: Middle East & Africa Organoids Market Share – by Method
11.1.1.4 United Arab Emirates: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.1.1.4.1 United Arab Emirates: Middle East & Africa Organoids Market Share – by Type
11.1.1.4.2 United Arab Emirates: Middle East & Africa Organoids Market Share – by Application
11.1.1.4.3 United Arab Emirates: Middle East & Africa Organoids Market Share – by Source
11.1.1.4.4 United Arab Emirates: Middle East & Africa Organoids Market Share – by Offering
11.1.1.4.5 United Arab Emirates: Middle East & Africa Organoids Market Share – by Instruments
11.1.1.4.6 United Arab Emirates: Middle East & Africa Organoids Market Share – by Consumables
11.1.1.4.7 United Arab Emirates: Middle East & Africa Organoids Market Share – by Method
11.1.1.5 Rest of Middle East & Africa: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.1.1.5.1 Rest of Middle East & Africa: Middle East & Africa Organoids Market Share – by Type
11.1.1.5.2 Rest of Middle East & Africa: Middle East & Africa Organoids Market Share – by Application
11.1.1.5.3 Rest of Middle East & Africa: Middle East & Africa Organoids Market Share – by Source
11.1.1.5.4 Rest of Middle East & Africa: Middle East & Africa Organoids Market Share – by Offering
11.1.1.5.5 Rest of Middle East & Africa: Middle East & Africa Organoids Market Share – by Instruments
11.1.1.5.6 Rest of Middle East & Africa: Middle East & Africa Organoids Market Share – by Consumables
11.1.1.5.7 Rest of Middle East & Africa: Middle East & Africa Organoids Market Share – by Method
12.1 Overview
12.2 Growth Strategies in Organoids Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13.1 STEMCELL Technologies Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Molecular Devices, LLC.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Hubrecht Organoid Technology
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Definigen
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Organoid Therapeutics
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Thermo Fisher Scientific Inc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Corning Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Merck KGaA
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 InSphero
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 ACRO Biosystems.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Bio-Techne Corp
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 SUN bioscience SA
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments
13.13 ORGANOID SCIENCES Co., Ltd.
13.13.1 Key Facts
13.13.2 Business Description
13.13.3 Products and Services
13.13.4 Financial Overview
13.13.5 SWOT Analysis
13.13.6 Key Developments
13.14 Crown Bioscience Inc
13.14.1 Key Facts
13.14.2 Business Description
13.14.3 Products and Services
13.14.4 Financial Overview
13.14.5 SWOT Analysis
13.14.6 Key Developments
13.15 Sartorius AG
13.15.1 Key Facts
13.15.2 Business Description
13.15.3 Products and Services
13.15.4 Financial Overview
13.15.5 SWOT Analysis
13.15.6 Key Developments
13.16 3D Biotek LLC
13.16.1 Key Facts
13.16.2 Business Description
13.16.3 Products and Services
13.16.4 Financial Overview
13.16.5 SWOT Analysis
13.16.6 Key Developments
13.17 Prellis Biologics Inc.
13.17.1 Key Facts
13.17.2 Business Description
13.17.3 Products and Services
13.17.4 Financial Overview
13.17.5 SWOT Analysis
13.17.6 Key Developments
13.18 3Dnamics Inc.
13.18.1 Key Facts
13.18.2 Business Description
13.18.3 Products and Services
13.18.4 Financial Overview
13.18.5 SWOT Analysis
13.18.6 Key Developments
13.19 Cellesce Ltd
13.19.1 Key Facts
13.19.2 Business Description
13.19.3 Products and Services
13.19.4 Financial Overview
13.19.5 SWOT Analysis
13.19.6 Key Developments
14.1 About The Insight Partners
Table 1. Middle East & Africa Organoids Market Segmentation
Table 2. Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
Table 3. Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Type
Table 4. Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Application
Table 5. Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Source
Table 6. Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Offering
Table 7. Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Method
Table 8. Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Country
Table 9. Saudi Arabia: Middle East & Africa Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Type
Table 10. Saudi Arabia: Middle East & Africa Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Application
Table 11. Saudi Arabia: Middle East & Africa Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Source
Table 12. Saudi Arabia: Middle East & Africa Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Offering
Table 13. Saudi Arabia: Middle East & Africa Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Instruments
Table 14. Saudi Arabia: Middle East & Africa Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Consumables
Table 15. Saudi Arabia: Middle East & Africa Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Method
Table 16. South Africa: Middle East & Africa Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Type
Table 17. South Africa: Middle East & Africa Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Application
Table 18. South Africa: Middle East & Africa Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Source
Table 19. South Africa: Middle East & Africa Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Offering
Table 20. South Africa: Middle East & Africa Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Instruments
Table 21. South Africa: Middle East & Africa Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Consumables
Table 22. South Africa: Middle East & Africa Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Method
Table 23. United Arab Emirates: Middle East & Africa Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Type
Table 24. United Arab Emirates: Middle East & Africa Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Application
Table 25. United Arab Emirates: Middle East & Africa Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Source
Table 26. United Arab Emirates: Middle East & Africa Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Offering
Table 27. United Arab Emirates: Middle East & Africa Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Instruments
Table 28. United Arab Emirates: Middle East & Africa Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Consumables
Table 29. United Arab Emirates: Middle East & Africa Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Method
Table 30. Rest of Middle East & Africa: Middle East & Africa Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Type
Table 31. Rest of Middle East & Africa: Middle East & Africa Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Application
Table 32. Rest of Middle East & Africa: Middle East & Africa Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Source
Table 33. Rest of Middle East & Africa: Middle East & Africa Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Offering
Table 34. Rest of Middle East & Africa: Middle East & Africa Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Instruments
Table 35. Rest of Middle East & Africa: Middle East & Africa Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Consumables
Table 36. Rest of Middle East & Africa: Middle East & Africa Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Method
Table 37. Recent Organic Growth Strategies in Organoids Market
Table 38. Recent Inorganic Growth Strategies in the Organoids Market
Figure 1. Middle East & Africa Organoids Market Segmentation – Country
Figure 2. Middle East & Africa Organoids Market – Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Middle East & Africa Organoids Market Revenue (US$ Million), 2021–2031
Figure 5. Middle East & Africa Organoids Market Share (%) – by Type (2023 and 2031)
Figure 6. Intestine: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 7. Liver: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 8. Stomach: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 9. Pancreas: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 10. Lung: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 11. Brain: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 12. Kidney: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 13. Others: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 14. Middle East & Africa Organoids Market Share (%) – by Application (2023 and 2031)
Figure 15. Developmental Biology Disease: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 16. Pathology of Infectious Disease: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 17. Regenerative Medicine: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 18. Drug Toxicity and Efficacy Testing: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 19. Drug Discovery and Personalized Medicine: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 20. Others: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 21. Middle East & Africa Organoids Market Share (%) – by Source (2023 and 2031)
Figure 22. Pluripotent Stem Cells: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 23. Organ-Specific Adult Stem Cell: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 24. Middle East & Africa Organoids Market Share (%) – by Offering (2023 and 2031)
Figure 25. Instruments: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 26. Consumables: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 27. Services: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 28. Middle East & Africa Organoids Market Share (%) – by Method (2023 and 2031)
Figure 29. Micropatterned Plates: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 30. Ultralow Attachment Plates: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 31. Hanging Drop: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 32. Microdroplet or Emulsion: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 33. Others: Middle East & Africa Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 34. Middle East & Africa Organoids Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 35. Saudi Arabia: Middle East & Africa Organoids Market – Revenue and Forecast, 2021– 2031 (US$ Million)
Figure 36. South Africa: Middle East & Africa Organoids Market – Revenue and Forecast, 2021– 2031 (US$ Million)
Figure 37. United Arab Emirates: Middle East & Africa Organoids Market – Revenue and Forecast, 2021– 2031 (US$ Million)
Figure 38. Rest of Middle East & Africa: Middle East & Africa Organoids Market – Revenue and Forecast, 2021– 2031 (US$ Million)
Figure 39. Growth Strategies in Organoids Market